PCRX Pacira BioSciences, Inc.
Healthcare$23.35-0.55%ClosedMarket Cap: $918.5M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$29.50
Target (Median)
$29.50
Target Range
$27.00 - $32.00
Upside from current price: 26.3%
Rating Distribution
1 Strong Buy3 Buy2 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-01 | Needham | maintain | Buy | Buy |
| 2026-05-01 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-03-26 | Barclays | maintain | Equal Weight | Equal Weight |
| 2026-01-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-09 | Needham | maintain | Buy | Buy |
| 2025-11-07 | Truist Securities | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $3.61 | $831.0M | 4 |
| Sun Dec 31 | $4.85 | $954.2M | 3 |
| Mon Dec 31 | $4.89 | $924.8M | 2 |
| Tue Dec 31 | $5.25 | $935.2M | 2 |